- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
ACADIA Pharmaceuticals Inc+ Add to Watchlist
ACAD:US19.4400 USD 0.1600 0.83%
As of 20:10:00 ET on 04/17/2014.
Company Profile for ACADIA Pharmaceuticals Inc (ACAD)
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
ACADIA Pharmaceuticals Inc
Key Executives for ACADIA Pharmaceuticals Inc (ACAD)
|Uli HacksellPresident/CEO||Roger M MillsExec VP:Dev/Chief Medical Ofcr|
|Glenn F BaityVP/Secy/General Counsel||Terrence O MooreExec VP/Chief Commercial Officer|
|Lisa BarthelemyDirector:Investor Relations|